12.06.2014 • NewsDede WillamsDiovanNovartis

Former Novartis Employee Suspected of Data Manipulation

A former employee of Novartis Pharma KK, the Japan unit of the Swiss drugmaker, has been arrested on suspicion of manipulating data to promote the company's best-selling blood pressure drug Diovan.

Nobuo Shiraishi is suspected of violating Japan's pharmaceutical laws by providing false data to researchers, whose work was intended for use in advertising the drug, the Tokyo District Public Prosecutor's Office said in a statement.

Novartis Pharma KK said it would cooperate with the investigation.

Anyone found guilty of exaggerated advertising of drugs in Japan can be punished with up to two years in prison or a fine of as much as 2 million yen ($19,600), or both.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.